Möchten Sie immer auf dem neuesten Stand bleiben?

Market growth is fueled by growing awareness of skin health, technological innovation, and expanding applications in both medical and cosmetic dermatology.

Report provides in-depth insights into technological developments, pipeline trends, and global opportunities shaping the future of bispecific antibodies.

“Global Oncology Biosimilars Market” is projected to grow from $9.6 billion in 2025 to $17.5 billion by the end of 2030, at a CAGR of 12.6%.

“Immunotherapy Drugs: Global Markets” is expected to grow from $260.7 billion in 2025 to reach $467.4 billion by the end of 2030, at a CAGR of 12.4% .

Growing demand for precision medicine and next-generation cancer therapies continues to fuel the global biological therapies market.

From renewable energy breakthroughs to climate tech innovations and advanced cancer treatments, these sectors are not just growing, but redefining future.

The global market for brain tumor therapeutics was valued at $2.5 billion in 2024 and is projected to reach $4.7 billion by the end of 2030.

Boston, Oct. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Molecular Diagnostics: Technologies and Global Markets” is projected to grow from $23 billion in 2025 to...

Boston, July 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Colonoscopes: Global Markets” is projected to reach $3.4 billion by the end of 2030, growing at a CAGR of...

Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...